Langsung ke konten utama

What Goes Downwards Mustn't Come Upward Up Says Canadian Copyright Board

Friend of the IPKat the MediaBeak (who said cats in addition to birds don’t become on?) brought the determination of the Canadian Copyright Board (reported on news.com) to the IPKat’s attention. The Board decided final Fri that uploading of P2P files is outlawed past times Canadian copyright law. However, because the Copyright Act allows earth to brand copies for personal piece of occupation in addition to does non address the source of those copies or whether the master has to live an authorised or non-infringing version, inwards sure as shooting circumstances at least, downloading P2P files may live permissible. The Board too imposed a levy on MP3 players, like to the levy payable on the buy of other recording devices, to brand upwardly for the revenues lost past times artists through personal copying. The determination has non been welcomed past times recording manufacture involvement groups such equally RIAA in addition to remains to live tested inwards the courts.

is puzzled past times this approach. Allowing downloading simply non uploading makes equally much feel to him equally legalising the taking of drugs simply non allowing drugs to live sold – how are the users or downloaders expected to obtain the items that the constabulary has said they are entitled to use? In the long run though, downloaders volition all the same accept to pay for the privilege of downloading, exclusively they are paying inwards advance through the levy on the equipment that enables them to brand piece of occupation of their downloads.

More logic problems here, here and here


Komentar

Postingan populer dari blog ini

Something To Read This Weekend

July-August Copyright World The electrical flow termination of Informa's colourful Copyright World has only reached the IPKat. The comprehend story is Google v Rest of the World - at least, it must experience that means to the giant moneymaker every bit it seeks to induce got on a vast array of vested interests inwards mature markets as well as technologies amongst its controversial Library Project. bets that this topic volition attain saturation point, replacing fifty-fifty P2P filesharing every bit the boringly predictable PhD thesis topic that all candidates desire to write. Full listing of contents here . Merpel's Must-Read : "Into the Honey Trap?", where the Copyright Terminator meets Winnie the Pooh. July-August MIP The July-August termination of Euromoney's Managing Intellectual Property lists the 50 close influential IP personalities of the year. Alas, afterwards the excitement of making the listing concluding fourth dimension round, the IPKat has been ...

No Prophylactic Trend To Intermission Up; Latest Ecdr

No rubber agency to interruption up This morning time the IPKat carried a greenback on Scansafe Ltd 5 Messagelabs Ltd , a Chancery Division conclusion from Mr Justice Patten which was noted on Lawtel. has since received an electronic mail from solicitors acting on behalf of Scansafe, informing him that the Lawtel greenback erroneously stated that Scansafe's application for injunctive relief was dismissed. Lawtel has since withdrawn its greenback in addition to the IPKat, non wishing to mislead his readers, has removed his greenback on the example too. Latest ECDR Issue four of the Sweet & Maxwell bimonthly European Copyright in addition to Design Reports has at i time been published. Cases available inwards English linguistic communication inwards this lawsuit include * L'Oréal SA 5 Bellure NV (Cour d'appel de Paris), on the protection of scents inwards French Republic every bit authors' works; * PlayStation (Tribunal of Bolzano, Italy), on the seizure of modern...

Gsk Gets That Ill Feeling Equally Antibiotic Patents Come Across An Early On Death

GlaxoSmithKline ( lost its activity to forbid Swiss fellowship Novartis making in addition to selling inexpensive generic versions of Augmentin , GSK's leading antibiotic. GSK’s proceedings were aimed both against Novartis in addition to its generic company, Geneva Pharmaceuticals . The United States Court of Appeals for the Federal Circuit ruled inwards favour of Novartis in addition to Geneva slow on Friday, upholding Geneva's claim that vii of GSK's patents for the drug were "improper in addition to should non bring been used to extend patent protection for [GSK's] product". Novartis in addition to Geneva surprised the marketplace inwards 2002 when it launched a generic version of Augmentin. The launch came afterwards an unexpected United States legal determination inwards May 2002 that a position out of GSK's patents for Augmentin were invalid. GSK spent over a twelvemonth fighting the determination only the master copy ruling has straight off bee...